500 related articles for article (PubMed ID: 15525550)
21. Differential expression of 11β-hydroxysteroid dehydrogenase type 1 and 2 in mild and moderate/severe persistent allergic nasal mucosa and regulation of their expression by Th2 cytokines: asthma and rhinitis.
Jun YJ; Park SJ; Hwang JW; Kim TH; Jung KJ; Jung JY; Hwang GH; Lee SH; Lee SH
Clin Exp Allergy; 2014 Feb; 44(2):197-211. PubMed ID: 24447082
[TBL] [Abstract][Full Text] [Related]
22. Cortisol metabolism and the role of 11beta-hydroxysteroid dehydrogenase.
Tomlinson JW; Stewart PM
Best Pract Res Clin Endocrinol Metab; 2001 Mar; 15(1):61-78. PubMed ID: 11469811
[TBL] [Abstract][Full Text] [Related]
23. Inhibitors of 11β-hydroxysteroid dehydrogenase type 1 in antidiabetic therapy.
Wang M
Handb Exp Pharmacol; 2011; (203):127-46. PubMed ID: 21484570
[TBL] [Abstract][Full Text] [Related]
24. Expression of 11β-hydroxysteroid dehydrogenase enzymes in human osteosarcoma: potential role in pathogenesis and as targets for treatments.
Patel P; Hardy R; Sumathi V; Bartle G; Kindblom LG; Grimer R; Bujalska I; Stewart PM; Rabbitt E; Gittoes NJ; Cooper MS
Endocr Relat Cancer; 2012 Aug; 19(4):589-98. PubMed ID: 22719058
[TBL] [Abstract][Full Text] [Related]
25. Alteration of the cortisol-cortisone shuttle in leprosy type 1 reactions in leprosy patients in Hyderabad, India.
Andersson AK; Atkinson SE; Khanolkar-Young S; Chaduvula M; Jain S; Suneetha L; Suneetha S; Lockwood DN
Immunol Lett; 2007 Mar; 109(1):72-5. PubMed ID: 17320974
[TBL] [Abstract][Full Text] [Related]
26. Characterisation of the cancer-associated glucocorticoid system: key role of 11β-hydroxysteroid dehydrogenase type 2.
Cirillo N; Morgan DJ; Pedicillo MC; Celentano A; Lo Muzio L; McCullough MJ; Prime SS
Br J Cancer; 2017 Sep; 117(7):984-993. PubMed ID: 28797028
[TBL] [Abstract][Full Text] [Related]
27. Characterization of 11beta-hydroxysteroid dehydrogenase activity in testicular tissue of control and GnRH-immunized boars as a possible regulator of spermatogenesis.
Claus R; Wagner A; Lambert T
Exp Clin Endocrinol Diabetes; 2005 May; 113(5):262-7. PubMed ID: 15926111
[TBL] [Abstract][Full Text] [Related]
28. Expression of 11beta-hydroxysteroid dehydrogenase types 1 and 2 in colorectal cancer.
Zbánková S; Bryndová J; Kment M; Pácha J
Cancer Lett; 2004 Jul; 210(1):95-100. PubMed ID: 15172126
[TBL] [Abstract][Full Text] [Related]
29. Tissue production of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 and metabolic disease.
Walker BR; Andrew R
Ann N Y Acad Sci; 2006 Nov; 1083():165-84. PubMed ID: 17148739
[TBL] [Abstract][Full Text] [Related]
30. The role of 11beta-hydroxysteroid dehydrogenases in the brain.
Holmes MC; Seckl JR
Mol Cell Endocrinol; 2006 Mar; 248(1-2):9-14. PubMed ID: 16413106
[TBL] [Abstract][Full Text] [Related]
31. IL-13-induced changes in endogenous glucocorticoid metabolism in the lung regulate the proasthmatic response.
Josephson MB; Jiao J; Xu S; Hu A; Paranjape C; Grunstein JS; Grumbach Y; Nino G; Kreiger PA; McDonough J; Grunstein MM
Am J Physiol Lung Cell Mol Physiol; 2012 Sep; 303(5):L382-90. PubMed ID: 22773690
[TBL] [Abstract][Full Text] [Related]
32. Growth hormone, insulin-like growth factor-I and the cortisol-cortisone shuttle.
Stewart PM; Toogood AA; Tomlinson JW
Horm Res; 2001; 56 Suppl 1():1-6. PubMed ID: 11786677
[TBL] [Abstract][Full Text] [Related]
33. 11beta-Hydroxysteroid dehydrogenase type 2 in pregnancy and preeclampsia.
Causevic M; Mohaupt M
Mol Aspects Med; 2007 Apr; 28(2):220-6. PubMed ID: 17532462
[TBL] [Abstract][Full Text] [Related]
34. Mast cells express 11β-hydroxysteroid dehydrogenase type 1: a role in restraining mast cell degranulation.
Coutinho AE; Brown JK; Yang F; Brownstein DG; Gray M; Seckl JR; Savill JS; Chapman KE
PLoS One; 2013; 8(1):e54640. PubMed ID: 23349944
[TBL] [Abstract][Full Text] [Related]
35. Evolution of 11beta-hydroxysteroid dehydrogenase-type 1 and 11beta-hydroxysteroid dehydrogenase-type 3.
Baker ME
FEBS Lett; 2010 Jun; 584(11):2279-84. PubMed ID: 20350543
[TBL] [Abstract][Full Text] [Related]
36. Use of 11alpha-deuterium labeled cortisol as a tracer for assessing reduced 11beta-HSD2 activity in vivo following glycyrrhetinic acid ingestion in a human subject.
Kasuya Y; Yokokawa A; Takashima S; Shibasaki H; Furuta T
Steroids; 2005 Feb; 70(2):117-25. PubMed ID: 15631868
[TBL] [Abstract][Full Text] [Related]
37. Characterization of activity and binding mode of glycyrrhetinic acid derivatives inhibiting 11β-hydroxysteroid dehydrogenase type 2.
Kratschmar DV; Vuorinen A; Da Cunha T; Wolber G; Classen-Houben D; Doblhoff O; Schuster D; Odermatt A
J Steroid Biochem Mol Biol; 2011 May; 125(1-2):129-42. PubMed ID: 21236343
[TBL] [Abstract][Full Text] [Related]
38. 11beta-hydroxysteroid dehydrogenase type 1 inhibitors as promising therapeutic drugs for diabetes: status and development.
Ge R; Huang Y; Liang G; Li X
Curr Med Chem; 2010; 17(5):412-22. PubMed ID: 20015040
[TBL] [Abstract][Full Text] [Related]
39. Obesity and corticosteroids: 11beta-hydroxysteroid type 1 as a cause and therapeutic target in metabolic disease.
Morton NM
Mol Cell Endocrinol; 2010 Mar; 316(2):154-64. PubMed ID: 19804814
[TBL] [Abstract][Full Text] [Related]
40. 11{beta}-Hydroxysteroid dehydrogenase 2 in rat leydig cells: its role in blunting glucocorticoid action at physiological levels of substrate.
Ge RS; Dong Q; Niu EM; Sottas CM; Hardy DO; Catterall JF; Latif SA; Morris DJ; Hardy MP
Endocrinology; 2005 Jun; 146(6):2657-64. PubMed ID: 15761036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]